HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Welcome! | |||
'''A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated in 2024; we're aligning the related CCGA content to the new structure.''' | '''A new version of the Heme/Lymphoid book (5th edition) is in beta form on the WHO website with publication of a final form anticipated in 2024; we're aligning the related CCGA content to the new structure.''' | ||
| Line 2,515: | Line 2,515: | ||
|[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Nicolas LaScala (trainee); | |[[HAEM5:T-large granular lymphocytic leukaemia|T-large granular lymphocytic leukaemia]]||Disease||Nicolas LaScala (trainee); | ||
Michelle Don, MD, MS | Michelle Don, MD, MS | ||
| | |9/24/2025 | ||
| | |12/9/2025 | ||
|Pending | |Pending | ||
| ||SK|| || | | ||SK|| || | ||
| Line 2,527: | Line 2,527: | ||
|[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Hailee St. Louis (trainee); | |[[HAEM5:NK-large granular lymphocytic leukaemia|NK-large granular lymphocytic leukaemia]]||Disease||Hailee St. Louis (trainee); | ||
Michelle Don, MD, MS | Michelle Don, MD, MS | ||
| | |9/24/2025 | ||
| | |12/9/2025 | ||
|Pending | |Pending | ||
| ||SK|| || | | ||SK|| || | ||
| Line 2,731: | Line 2,731: | ||
| || || || ||SK|| || | | || || || ||SK|| || | ||
|Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) | |Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS) | ||
|Derick Okwan MD, PhD (Stanford | |Derick Okwan MD, PhD (Stanford) Sumire Kitahara MD (Cedars-Sinai) | ||
|Complete | |Complete | ||
|9/26/2022 | |9/26/2022 | ||
| Line 2,738: | Line 2,738: | ||
|[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Forough Sargolzaeiaval (trainee); | |[[HAEM5:Hepatosplenic T-cell lymphoma|Hepatosplenic T-cell lymphoma]]||Disease||Forough Sargolzaeiaval (trainee); | ||
Michelle Don, MD, MS | Michelle Don, MD, MS | ||
| | |9/24/2025 | ||
| | |11/9/2025 | ||
| | |Pending | ||
|5/13/24||SK||10/18/24|| | |Old template completed 5/13/24||SK||10/18/24|| | ||
|Hepatosplenic T-cell Lymphoma | |Hepatosplenic T-cell Lymphoma | ||
|Michelle Don, MD, MS | |Michelle Don, MD, MS | ||
| Line 2,774: | Line 2,774: | ||
|- | |- | ||
|[[HAEM5:Breast implant-associated anaplastic large cell lymphoma|Breast implant-associated anaplastic large cell lymphoma]]||Disease||Lynne Abruzzo, MD, PhD | |[[HAEM5:Breast implant-associated anaplastic large cell lymphoma|Breast implant-associated anaplastic large cell lymphoma]]||Disease||Lynne Abruzzo, MD, PhD | ||
| | |9/22/2025 | ||
|1/1/2026 | |||
|Pending|| ||SK|| || | |||
|Breast Implant-Associated Anaplastic Large Cell Lymphoma | |Breast Implant-Associated Anaplastic Large Cell Lymphoma | ||
|Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | |Derick Okwan-Duodu, MD, PhD; Sumire Kitahara, MD Cedars-Sinai Medical Center | ||